Clinical trials
Anxiety Disorder (Panic Disorder or GAD) clinical trials
Below are recruiting anxiety disorder (panic disorder or gad) clinical trials, each written for real people, not researchers. We’re tracking 205 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05663489Recruiting
Brain and treatment response study for anxiety and OCD
This study looks at brain-related measurements to see how people with anxiety or OCD respond to a short, intensive clinic treatment. It may help researchers understand who benefits most and why, using optional brain-scan data in some participants.
Bergen, VestlandAges 16 years+ - NCT07807865RecruitingPhase 3
Testing a new anxiety medication for safety
This study is testing a new medication for generalized anxiety disorder. It will check if the drug is safe and well-tolerated when taken alone or alongside your current anxiety treatment.
Los Angeles, CaliforniaAges 18 years+ - NCT07798063Recruiting
Solution-focused therapy for generalized anxiety
This study tests a type of talk therapy called solution-focused therapy to help young adults with mild to moderate generalized anxiety. It may help you learn practical ways to manage anxiety and improve your well-being.
IslamabadAges 18–29 - NCT07429578Recruiting
Brain stimulation for anxiety and insomnia
This study tests whether a gentle, non-invasive brain stimulation technique (tACS) can help people who have both generalized anxiety and long-term sleep problems. It aims to see if this treatment can reduce anxiety and improve sleep.
São Paulo, São PauloAges 18–65 - NCT07201844Recruiting
Does patient choice improve online anxiety treatment?
This trial tests whether letting patients choose their own treatment approach within an online therapy program helps them more for generalized anxiety disorder. You'd receive 10 weeks of internet-delivered cognitive behavior therapy (iCBT) from home.
Stockholm, SverigeAges 18 years+ - NCT06969170RecruitingPhase 2
Psilocybin oral solution for generalized anxiety disorder trial
This study tests a psilocybin oral solution in adults with generalized anxiety disorder (GAD). It aims to see if the drug is safe, tolerable, and helpful for reducing anxiety symptoms.
Kingston, OntarioAges 18–60 - NCT06931236Enrolling by invitation
Brain stimulation for anxiety and insomnia
This study tests whether a noninvasive brain stimulation technique called rTMS can help people with both anxiety and insomnia. Treatments target a specific brain region to reduce anxiety and improve sleep.
Hefei, AnhuiAges 15–65 - NCT06846320RecruitingPhase 2
Study of ABBV-932 for generalized anxiety disorder
This trial tests an oral medicine called ABBV-932 when added to current antidepressant therapy for people with generalized anxiety disorder (GAD) who still have symptoms. It aims to see if the combination can improve anxiety and reduce side effects.
Huntsville, AlabamaAges 18–65 - NCT06512324Enrolling by invitation
TMS with remote viewing for depression and anxiety
This trial tests whether adding 'remote viewing' (a technique where a person tries to perceive a distant target) to standard TMS brain stimulation can improve depression and anxiety symptoms. It is for people already getting TMS and who can attend weekly visits.
Encinitas, CaliforniaAges 12 years+ - NCT04557891Recruiting
Low-intensity ultrasound for generalized anxiety disorder
This trial tests a non-drug brain treatment using low-intensity focused ultrasound to reduce symptoms of generalized anxiety disorder (GAD). It may help if your anxiety has been moderate to severe and you’ve already tried standard medications without enough relief.
Los Angeles, CaliforniaAges 18–65 - NCT05527509Recruiting
Study of risk and resilience in new RCMP cadets
This study follows people as they start RCMP Cadet Training to learn what factors affect “risk” and “resilience” (how well someone adapts under stress). It may help improve support for cadets during training.
Regina, SaskatchewanAges 19–57 - NCT06823024Enrolling by invitation
Using speech patterns to predict treatment response in depression, PTSD, or bipolar disorder
This study tests if a computer algorithm can analyze your speech to predict how well you will respond to treatments like TMS or Spravato. It aims to create a simple tool that helps doctors choose the right treatment for you.
Sunnyvale, CaliforniaAges 18–68 - NCT07604753Recruiting
Comparing two mental health screening questionnaires
This study compares two different questionnaires that doctors use to diagnose mental health conditions. Researchers want to check if a newer, shorter questionnaire works just as well as the longer standard one.
Hong KongAges 18 years+ - NCT07819773Recruiting
Device for treating generalized anxiety
This study tests a device that uses magnetic pulses to stimulate the brain, which may help reduce symptoms of generalized anxiety disorder (GAD). The treatment is non-invasive and does not require surgery.
Denver, ColoradoAges 22 years+ - NCT07748091Recruiting
Brain wave and inflammation markers in shock therapy for depression
This study looks at brain wave patterns and markers of inflammation in people with depression that hasn't improved with other treatments and who are receiving electroconvulsive therapy (ECT, also known as shock therapy). The goal is to understand how these markers might relate to how well ECT works.
Istanbul, BakırköyAges 18–60 - NCT07740694Recruiting
ECT study for older adults with depression
This study looks at how ECT affects brain activity and inflammation in older adults with depression. It may help researchers understand why ECT works and improve treatment.
Istanbul, BakırköyAges 55 years+ - NCT07430800Recruiting
AI-Powered CBT for Anxiety in University Students
This study tests whether personalized computer models can improve cognitive behavioral therapy (a talk therapy that helps change thinking patterns) for anxiety. It's for university students who have mild to moderate anxiety and are comfortable with being recorded during sessions.
Los Angeles, CaliforniaAges 18 years+ - NCT07299916Enrolling by invitation
Brain stimulation and virtual reality for anxiety disorders
This trial tests if a combination of non-invasive brain stimulation (tDCS) and virtual reality meditation can reduce anxiety in people with Generalized Anxiety Disorder or related conditions. It aims to find a new, non-medication way to help manage symptoms.
Hong KongAges 16–70 - NCT05549102Recruiting
CBT therapy study for anxiety and brain circuit changes
This trial studies whether a specific form of talk therapy (CBT) changes brain activity in people with moderate anxiety. It may help your care team understand what works best and how brain “circuits” respond to treatment.
LondonAges 18–64 - NCT06243640RecruitingPhase 3
New capsule for generalized anxiety disorder trial
This trial tests a new capsule called Buagafuran for adults with generalized anxiety disorder (GAD). It aims to see if the medication helps reduce anxiety without causing major side effects.
Beijing, Beijing MunicipalityAges 18–65 - NCT06243614RecruitingPhase 3
Testing buagafuran capsules for generalized anxiety disorder
This trial tests a new medication called buagafuran for people with generalized anxiety disorder (GAD). It aims to see if the drug can safely reduce anxiety symptoms.
Beijing, Beijing MunicipalityAges 18–65 - NCT06831708Recruiting
Comparing two types of talk therapy for generalized anxiety
This trial compares two short-term therapies—psychoanalytic and cognitive behavioral—for people with generalized anxiety disorder (GAD). It aims to see which approach works better over 12 weekly sessions.
IstanbulAges 18–65 - NCT03813290Recruiting
Brain-based therapy for teens with generalized anxiety
This trial tests a neuro-based treatment to help adolescents with generalized anxiety disorder, including those newly diagnosed. You may be able to join if you meet age, diagnosis, and safety requirements, and if you have not already tried certain mindfulness programs.
Singapore, SingaporeAges 13–18 - NCT06514495Recruiting
Virtual vs. real-life therapy for agoraphobia
This study compares facing fears in virtual reality versus real-life situations for people with agoraphobia. Researchers want to see which method works better to reduce anxiety.
MainzAges 18–75
Hear when a new Anxiety Disorder (Panic Disorder or GAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for anxiety disorder (panic disorder or gad)?
- Yes. Clin2 currently lists 205 recruiting anxiety disorder (panic disorder or gad) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a anxiety disorder (panic disorder or gad) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a anxiety disorder (panic disorder or gad) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.